← FDA Drug Approvals (Drugs@FDA)
XANAX XR
NDA · New Drug Application · Sponsor: UPJOHN · Approved 2003-01-17
Drug application
- FDA Application #
NDA021434- Application type
- New Drug Application
- Brand name
- XANAX XR
- Generic name
- ALPRAZOLAM
- Active ingredients
- ALPRAZOLAM
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- UPJOHN
- Manufacturer
- Viatris Specialty LLC
- First approval
- 2003-01-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown